In a report released today, Matt Miksic from Barclays maintained a Sell rating on Zimmer Biomet Holdings (ZBH – Research Report), with a price ...

Shares of Zimmer Biomet Holdings Inc. ZBH dropped 0.98% to $108.40 Tuesday, on what proved to be an all-around grim trading ...

Barclays analyst Matt Miksic lowered the firm’s price target on Zimmer Biomet (ZBH) to $118 from $125 and keeps an Underweight rating on the ...

We recently compiled a list of the 11 Best Cosmetic Surgery and Aesthetics Stocks to Invest in Now. In this article, we are ...

Zimmer Biomet Holdings, Inc. has a 52 week low of $101.47 and a 52 week high of $133.90. The company has a fifty day simple moving average of $107.52 and a two-hundred day simple moving average of ...

WARSAW, Ind., Dec. 4, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k ...

Zimmer Biomet had a strong 2024, bolstering its product lines and staying on top of orthopedic medtech trends.

WARSAW, Ind., Dec. 4, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Zimmer Biomet has scored an FDA clearance for a new component of its total knee replacement offering, aimed at patients who may be sensitive to certain metals or bone cement. The Persona SoluTion ...